TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34351020

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short-course glucocorticoids (GC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FcRn blockers (SYNT001)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rilzabrutinib (PRN1008)
Number of subjects: 0
Study: 34764037

Group type: EXPERIMENTAL
Intervention: Access to ImmsLink software and training for pharmacists
Number of subjects: 501
Study: 32493407

Group type: COMPARATOR
Intervention: Immediate orally administered amoxicillin (clarithromycin)
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Immediate ciprofloxacin 0.3% eardrops
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Delayed orally administered amoxicillin (clarithromycin if penicillin allergic)
Number of subjects: 399
Study: 35128820

Group type: EXPERIMENTAL
Intervention: 20 g/day SQ-LNS
Number of subjects: 735

Group type: COMPARATOR
Intervention: Control (no dietary supplementation)
Number of subjects: 735
Study: 34347254

Group type: EXPERIMENTAL
Intervention: 150 mg capecitabine (test formulation)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Branded reference formulation
Number of subjects: 48
Study: 36205814

Group type: EXPERIMENTAL
Intervention: Mixed Circuit Training (MCT)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (CTL)
Number of subjects: 7
Study: 33651758

Group type: EXPERIMENTAL
Intervention: Visual feedback
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Just-in-time CPR training
Number of subjects: 10

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 10
Study: 36809520

Group type: EXPERIMENTAL
Intervention: Spirituality-based palliative care (four 120-min sessions)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 80
Study: 32642953

Group type: EXPERIMENTAL
Intervention: Dental extraction + PBMT (n = 19)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dental extraction + sham-PBMT (n = 21)
Number of subjects: 40
Study: 34254318

Group type: COMPARATOR
Intervention: Anti-racist recommendations proposed by Professors N. Patel, R. Smith, or no one (control)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Anti-racist recommendations
Number of subjects: 395

Group type: COMPARATOR
Intervention: White students
Number of subjects: 395
Study: 34666734

Group type: EXPERIMENTAL
Intervention: Arthroscopic subacromial decompression
Number of subjects: 184

Group type: COMPARATOR
Intervention: Diagnostic arthroscopy
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 184
Study: 32881921

Group type: EXPERIMENTAL
Intervention: Progressive active mobilization with dose and training load control
Number of subjects: 118

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 118
Study: 36153475

Group type: EXPERIMENTAL
Intervention: Itacitinib (a selective JAK1 inhibitor) combined with ASTX727 (a fixed dose oral combination of decitabine and cedazuridine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 32244170

Group type: EXPERIMENTAL
Intervention: Scopolamine-augmentation during exposure therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo during exposure therapy
Number of subjects: 60
Study: 35785595

Group type: EXPERIMENTAL
Intervention: Tislelizumab
Number of subjects: 512

Group type: COMPARATOR
Intervention: Investigator-chosen chemotherapy (ICC)
Number of subjects: 512
Study: 32600189

Group type: EXPERIMENTAL
Intervention: Structured patient education intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no structured patient education)
Number of subjects: 80
Study: 32278848

Group type: EXPERIMENTAL
Intervention: Out-of-pocket cost information provided by LCS centers
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Accessibility of cost information via telephone or website
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Facility and state-level characteristics
Number of subjects: 55
Study: 35746522

Group type: EXPERIMENTAL
Intervention: Half-dose BNT162b2 (15 µg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard-dose BNT162b2 (30 µg)
Number of subjects: 100
Study: 33755149

Group type: EXPERIMENTAL
Intervention: WDTE60N (150 mg curcuminoids)
Number of subjects: 14

Group type: COMPARATOR
Intervention: STE95 (500 mg curcuminoids each)
Number of subjects: 14
Study: 35634544

Group type: EXPERIMENTAL
Intervention: Madhav Rasayan Plus tablets (250 mg) twice a day for 15 days, along with standard care (SOC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: SOC alone
Number of subjects: 40
Study: 33413452

Group type: EXPERIMENTAL
Intervention: HK Chinese SF‐12v2
Number of subjects: 1013

Group type: COMPARATOR
Intervention: English SF‐12v2
Number of subjects: 1013
Study: 36269582

Group type: EXPERIMENTAL
Intervention: Anatomic double-bundle (DB) technique
Number of subjects: 105

Group type: COMPARATOR
Intervention: Anatomic single-bundle (SB) technique
Number of subjects: 105
Study: 34670502

Group type: EXPERIMENTAL
Intervention: Tailored Activity Program (TAP)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Attention Control
Number of subjects: 250
Study: 32334146

Group type: EXPERIMENTAL
Intervention: Informational video
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Narrative video
Number of subjects: 455
Study: 35325125

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 29
Study: 34779293

Group type: EXPERIMENTAL
Intervention: Pilates Exercises (PE)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Aerobic Exercises (AE)
Number of subjects: 52
Study: 34733674

Group type: EXPERIMENTAL
Intervention: Vitamin A palmitate (VAP) eye gel
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Watson's theory of care nursing + VAP eye gel
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Watson's theory of care nursing
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (no VAP eye gel)
Number of subjects: 240
Study: 35930850

Group type: EXPERIMENTAL
Intervention: Applied Relaxation (AR) training
Number of subjects: 277

Group type: COMPARATOR
Intervention: Assessment-only control group (CG)
Number of subjects: 277
Study: 33327452

Group type: EXPERIMENTAL
Intervention: Family-facilitated problem-solving based self-learning program (PBSP) in addition to usual care
Number of subjects: 114

Group type: COMPARATOR
Intervention: Family psychoeducation group program and usual psychiatric care
Number of subjects: 114
Study: 35690026

Group type: EXPERIMENTAL
Intervention: ANS comparison training
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: ANS arithmetic training
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 87
Study: 33871949

Group type: EXPERIMENTAL
Intervention: ADSCs-assisted AFG (5 × 10^5 ADSCs/mL fat)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: SVF-assisted AFG (SVF:fat ratio of 1:1)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional AFG
Number of subjects: 18
Study: 32884253

Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Salmeterol/fluticasone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Achieving ECII (D1: ≥4-unit reduction in St. George’s Respiratory Questionnaire; D2: ≥2-point reduction in COPD assessment test)
Number of subjects: 0
Study: 33243533

Group type: EXPERIMENTAL
Intervention: Oral magnesium replacement (along with acetaminophen and ondansetron)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (acetaminophen and ondansetron)
Number of subjects: 0
Study: 35477611

Group type: EXPERIMENTAL
Intervention: REL-1017 25 mg QD
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: REL-1017 50 mg QD
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 33400384

Group type: EXPERIMENTAL
Intervention: Reminiscence therapy‐based care program (RTCP)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control care program (CCP)
Number of subjects: 192
Study: 33634859

Group type: EXPERIMENTAL
Intervention: Benign thyroid diseases (hyperthyroidism)
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: Family history of TC
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: Radiation exposure of the head
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: Family history of thyroid diseases
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: Family history of other types of cancer
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: High blood pressure
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: Higher education (college vs. illiterate)
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: Consumption of unsaturated fat (vs. saturated)
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: Being married (vs. single)
Number of subjects: 708
Study: 32302246

Group type: EXPERIMENTAL
Intervention: SPW exercises with six weekly sessions and home practice
Number of subjects: 37

Group type: COMPARATOR
Intervention: Vocal hygiene education
Number of subjects: 37
Study: 34215784

Group type: EXPERIMENTAL
Intervention: High-potency cannabis flower with CBD
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High-potency cannabis flower without CBD
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High-potency cannabis concentrates with CBD
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High-potency cannabis flower with CBD, high-potency flower without CBD, and high-potency concentrates
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: CBD (in high-potency cannabis products)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High-potency cannabis concentrates
Number of subjects: 80
Study: 35192206

Group type: EXPERIMENTAL
Intervention: Hand preparation with medicated solution (4% w/v chlorhexidine bigluconate followed by an ABHR)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Application of a medication solution (benzalkonium chloride 0.1%‐1% and polymeric biguanide hydrochloride 0.01%‐0.1%) followed by an ABHR
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Nonmedicated pH‐neutral soap hand wash followed by ABHR
Number of subjects: 103

Group type: COMPARATOR
Intervention: Direct application of an ABHR
Number of subjects: 103
Study: 34307321

Group type: EXPERIMENTAL
Intervention: PVRP (autologous platelet- and extracellular vesicle-rich plasma)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard conservative methods (control group)
Number of subjects: 22
Study: 35791755

Group type: EXPERIMENTAL
Intervention: Mirikizumab 250 mg Q4W
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Mirikizumab 250 mg Q4W/125 mg Q8W
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Mirikizumab 250 mg Q4W/250 mg Q8W
Number of subjects: 530

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 530

Group type: COMPARATOR
Intervention: Placebo Q8W
Number of subjects: 530
Study: 32248403

Group type: EXPERIMENTAL
Intervention: Teledermatology group (n=50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (n=50)
Number of subjects: 100
Study: 36123240

Group type: EXPERIMENTAL
Intervention: Periarticular analgesia with ropivacaine 300 mg and morphine 5 mg, diluted with saline to 50 ml, plus tranexamic acid (TXA) 2 g injected into the articular cavity after surgery.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intraarticular injection of 70 mL mixture (ropivacaine 300 mg, morphine 5 mg, and TXA 2 g) after stitching of the joint capsule.
Number of subjects: 100
Study: 32072838

Group type: EXPERIMENTAL
Intervention: Parental self-efficacy in asthma care
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Confidence in using medications correctly
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Having inhalers during a child's serious breathing problem
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Knowing which medications to use during a child's serious breathing problem
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Hispanic/Latino ethnicity of the child
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Asthma Control Test scores
Number of subjects: 252
Study: 32530523

Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 3057

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 3057
Study: 35277404

Group type: EXPERIMENTAL
Intervention: Pharmacist-participated medication reconciliation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 32029487

Group type: EXPERIMENTAL
Intervention: High-dose haemodiafiltration (HDF)
Number of subjects: 1800

Group type: COMPARATOR
Intervention: High-flux haemodialysis (HD)
Number of subjects: 1800
Study: 34301679

Group type: EXPERIMENTAL
Intervention: Malay ethnicity
Number of subjects: 915

Group type: EXPERIMENTAL
Intervention: Indian ethnicity
Number of subjects: 915

Group type: EXPERIMENTAL
Intervention: Housing type (one to three rooms)
Number of subjects: 915

Group type: EXPERIMENTAL
Intervention: Housing type (four to five rooms public housing)
Number of subjects: 915

Group type: EXPERIMENTAL
Intervention: Lower SES
Number of subjects: 915
Study: 32220632

Group type: EXPERIMENTAL
Intervention: SAHELI intervention (group-based lifestyle change program with weekly classes for 16 weeks and 4 booster classes through month 11)
Number of subjects: 550

Group type: COMPARATOR
Intervention: Printed healthy lifestyle education materials (control group)
Number of subjects: 550
Study: 35046509

Group type: EXPERIMENTAL
Intervention: Physostigmine (1 mg)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 34334102

Group type: EXPERIMENTAL
Intervention: Injury-preventive warmup protocol (PEP)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard warmup protocol
Number of subjects: 18
Study: 36255427

Group type: EXPERIMENTAL
Intervention: Spinal cord burst stimulation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 50
Study: 34127632

Group type: EXPERIMENTAL
Intervention: Low-level secretors (LLS)
Number of subjects: 16
Study: 35229557

Group type: EXPERIMENTAL
Intervention: Renal Transplant (RT) patients
Number of subjects: 90

Group type: COMPARATOR
Intervention: Dialysis patients
Number of subjects: 90
Study: 34096066

Group type: EXPERIMENTAL
Intervention: Points gain condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Points loss condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Informative-only feedback condition
Number of subjects: 0
Study: 33045870

Group type: EXPERIMENTAL
Intervention: J-shaped stylet
Number of subjects: 222

Group type: COMPARATOR
Intervention: 60° stylet
Number of subjects: 222
Study: 35325831

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg PQQ.Na2
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 1 mg/kg PQQ.Na2
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 2 mg/kg PQQ.Na2
Number of subjects: 96

Group type: COMPARATOR
Intervention: 0 mg/kg PQQ.Na2 (Control)
Number of subjects: 96
Study: 35917826

Group type: EXPERIMENTAL
Intervention: Low-Dose Computed Tomography (LDCT) screening at baseline and after 12 months
Number of subjects: 12100

Group type: COMPARATOR
Intervention: Control group of low-risk participants
Number of subjects: 12100
Study: 33673158

Group type: EXPERIMENTAL
Intervention: OP group (OPTIFAST®)
Number of subjects: 273

Group type: COMPARATOR
Intervention: FB group (food-based dietary intervention)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 273
Study: 33847066

Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone acetonide (IVTA) 4 mg/0.1 cc at the end of surgery
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Topical nepafenac sodium 0.1% TID for 1 month post-operation
Number of subjects: 80

Group type: COMPARATOR
Intervention: No adjuvant therapy (NAT)
Number of subjects: 80
Study: 33594912

Group type: EXPERIMENTAL
Intervention: ECG‐EM guidance
Number of subjects: 120

Group type: COMPARATOR
Intervention: FX guidance
Number of subjects: 120
Study: 36001405

Group type: EXPERIMENTAL
Intervention: Self-hypnosis and self-care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical hypnosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Online hypnosis intervention
Number of subjects: 0
Study: 32069742

Group type: EXPERIMENTAL
Intervention: Short-term stay in a mountainous, climate-cooler setting (mean ± SD: 7 ± 3 days)
Number of subjects: 31
Study: 34775221

Group type: EXPERIMENTAL
Intervention: Synbiotics group
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study: 32709920

Group type: EXPERIMENTAL
Intervention: Deltamethrin 0.64 mg a.i./L
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Deltamethrin 1.40 mg a.i./L
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Deltamethrin 15.03 mg a.i./L
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Deltamethrin doses < 3.10 mg a.i./L
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Deltamethrin doses > 3.10 mg a.i./L
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (distilled water)
Number of subjects: 10
Study: 36432420

Group type: EXPERIMENTAL
Intervention: Intermittent fasting 5:2 plus (n = 42)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Daily calorie restriction (n = 41)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Daily calorie restriction with meal replacement (n = 48)
Number of subjects: 131
Study: 33902400

Group type: EXPERIMENTAL
Intervention: N95 mask during maximal exercise intensity (N95MAX)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: SURGICAL mask during maximal exercise intensity (SURMAX)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: N95 mask during submaximal exercise intensity (N95SUB)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: SURGICAL mask during submaximal exercise intensity (SURSUB)
Number of subjects: 144

Group type: COMPARATOR
Intervention: NO MASK
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: N95 mask for females
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Hematological function
Number of subjects: 144
Study: 33440370

Group type: COMPARATOR
Intervention: Ascitic fluid IL‐4, IL‐6, and IL‐10 levels in patients with hepatocellular carcinoma (HCC)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Ascitic fluid TNF‐α and IFN‐γ levels in patients with hepatocellular carcinoma (HCC)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Ascitic fluid IL‐1B and IL‐2 levels
Number of subjects: 45

Group type: COMPARATOR
Intervention: Ascitic fluid IL‐2 and IL‐10 levels
Number of subjects: 45

Group type: COMPARATOR
Intervention: Ascitic fluid levels of IL‐4, IL‐6, and IL‐10
Number of subjects: 45
Study: 32172380

Group type: EXPERIMENTAL
Intervention: Genetic predisposition to higher concentration of low-density lipoprotein particles (LDL.P)
Number of subjects: 34217

Group type: EXPERIMENTAL
Intervention: Genetic predisposition to cholesterol carried in different sizes of LDL.P (LDL.C)
Number of subjects: 34217

Group type: EXPERIMENTAL
Intervention: Genetically predicted LDL.P
Number of subjects: 34217

Group type: EXPERIMENTAL
Intervention: Genetically predicted LDL.C
Number of subjects: 34217
Study: 34619108

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg once daily
Number of subjects: 4304

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4304
Study: 32243363

Group type: EXPERIMENTAL
Intervention: Scaling and Root Planing + PDT
Number of subjects: 34

Group type: COMPARATOR
Intervention: Scaling and Root Planing + PDT placebo
Number of subjects: 34
Study: 33725859

Group type: EXPERIMENTAL
Intervention: Supervised heavy‐load resistance training (RT) twice a week over the course of chemotherapy (approximately 16‐weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual activities (Control group)
Number of subjects: 50
Study: 32012398

Group type: EXPERIMENTAL
Intervention: Nurse-led education pathway
Number of subjects: 180

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 180
Study: 34351566

Group type: EXPERIMENTAL
Intervention: Viscoelastic group (0.15‐0.2 mL of 1.7% sodium hyaluronate injected into the anterior chamber)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Air group (anterior chamber filled with air after FCVB implant surgery)
Number of subjects: 30
Study: 616121226

Group type: EXPERIMENTAL
Intervention: Intravitreal Aflibercept (IAI) single injection (2.0 mg 5 days prior to surgery)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intravitreal Aflibercept (IAI) double injection (2.0 mg 5 days prior to surgery and additional injection at the time of surgery)
Number of subjects: 12
Study: 34010747

Group type: EXPERIMENTAL
Intervention: 40 g of EVOO-enriched chocolate
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control chocolate spread
Number of subjects: 25
Study: 33353067

Group type: EXPERIMENTAL
Intervention: Aerobic dance on an air dissipation platform (ADP)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Aerobic dance on a hard surface
Number of subjects: 25
Study: 35818141

Group type: EXPERIMENTAL
Intervention: Timothy grass SLIT-tablet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Five-grass SLIT-tablet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ragweed SLIT-tablet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: House-dust mite SLIT-tablet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tree SLIT-tablet
Number of subjects: 0

Group type: COMPARATOR
Intervention: SLIT-tablets
Number of subjects: 0
Study: 33792376

Group type: EXPERIMENTAL
Intervention: Olanzapine 5 mg
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Olanzapine 10 mg
Number of subjects: 68

Group type: COMPARATOR
Intervention: Ondansetron and dexamethasone
Number of subjects: 68
Study: 32248662

Group type: EXPERIMENTAL
Intervention: Proposed interim decision procedure based on conditional power approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard approaches
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed methods in adaptive designs
Number of subjects: 0
Study: 35358319

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care interventions (PC)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Traditional care (Control arm)
Number of subjects: 206
Study: 34312486

Group type: EXPERIMENTAL
Intervention: DoubledyneTM
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: TwinTM
Number of subjects: 144
Study: 34666724

Group type: EXPERIMENTAL
Intervention: Strengthening Families, Strengthening Communities (SFSC) parenting programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 0